Page 9 - CiTRUS Demo

We engage with clients in the early stages of drug development
We follow a rigorous process of steps and milestones for assets to ensure development of the optimal value and evidence strategy
Phase 1
Broad perspective:
Scientific, clinical, and regulatory feasibility
Phase 3
Ability to align diverse functional partners:
R&D – Clinical Development – Regulatory – Medical – Commercial – Market Access Key corporate functions must inform and agree on the Clinical Development Plan (CDP)
EARLY DEVELOPMENT
PIVITOL TRIALS
Phase 2
Validation of trial designs:
Test trial designs, TPP scenarios with clinicians, patients, and payers
LAUNCH SUBMISSIONS
HOLISTIC LIFESTYLE PLAN
Phase 4
Holistic Lifecycle Plan:
Stay ahead of follow-on indication assessments Develop indication sequence
early in development
9